ArticleEClinicalMedicine2026

Nivolumab with definitive chemoradiotherapy for oesophageal squamous cell carcinoma (NOBEL): a multicentre, single-arm, phase 2 feasibility trial.

Motoo Nomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.